Clinical Trial Update: Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating methylene blue MMX tablets to detect neoplasia during colonoscopy in patients with ulcerative colitis; results have been posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Methylene Blue MMX Tablets (methylene blue)

Snippet

Sponsor: Cosmo Technologies Ltd | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2019-02-08